NASDAQ: AVRO - AVROBIO, Inc.

Yield per half year: +19.84%
Sector: Healthcare

AVROBIO, Inc.

Underestimation
Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
10/10
5.1 48.77 -89.55% -5.82 -187.57%
P/S 0 33.76 -100%
P/BV 0.6539 4.82 -86.44%
P/FCF -1.06 60.98 -101.74%
Ev/Ebitda 0.4993 -22.12 -102.26%
Ev/S 0 22.56 -100%
Ev/FCF 0.5613 68.75 -99.18%
E/P 0.1809 0.0178 917.8%
Efficiency
Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
0/10
0 4.83 -100% 0 0%
ROE 12.83 9.61 33.58%
ROA 12.03 0.3359 3480.04%
ROIC -60.11 7.63 -887.36%
ROS 0 -25.17 -100%
ROCE -75.65 15.33 -593.42%
Debt
Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
-0.0124 -3.67 -99.66% -0.0771 -83.98%
Nеt Debt/Ebitda 1.37 -3.44 -139.87%
Debt/Ratio 0.0087 0.1972 -95.59%
Debt/Equity 0.3028 1.65 -81.61%
Debt/Net Income 0.0722 10.31 -99.3%
Dividends
Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 0.5491 -100% 0 0%
Number of years of dividend growth 0 0.0789 -100%
DSI 0 0.2043 -100%
Average dividend growth 0 0.0591 -100%
Average percentage for 5 years 0 0.4924 -100%
Average percentage for payments 131.85 43.56 202.66%
Difference from average difference in sector -0.5491
Growth impulse
Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue 5 years
0/10
0 -56.89 -100%
Growth impulse Ebitda 5 years -6.27 -64.81 -90.33%
Growth impulse Net Income 5 years -117.54 -58.33 101.51%
Growth impulse FCF 5 years -8.81 -47 -81.26%
Growth impulse EPS 5 years -110.78 -32.41 241.81%
IP Score
4.15/10

Similar companies

Amgen

Alexion

ABIOMED

Gilead Sciences